Ribociclib News

6 Aug 20261:56 am

Pharmaceuticals6 Aug 2026 · 1:56 am1:56 am

Delhi HC Seeks Response on Natco's Patent Challenge Plea Against Novartis

The Delhi High Court is examining Natco Pharma's petition challenging a breast cancer drug patent held by Novartis and Astex. Natco claims the two companies sec

5 Aug 202610:04 pm

Legal5 Aug 2026 · 10:04 pm10:04 pm

Create visual

Natco Challenges Novartis's Second Ribociclib Patent in Delhi High Court

Natco has challenged Novartis's second patent for the cancer drug ribociclib in the Delhi High Court, alleging it unlawfully extends Novartis's market monopoly

Ribociclib News

#Ribociclib

Delhi HC Seeks Response on Natco's Patent Challenge Plea Against Novartis

Natco Challenges Novartis's Second Ribociclib Patent in Delhi High Court

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs